Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol)

NCT00634556 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Tourette Syndrome

Interventions

DRUG: levodopa solution 2mg/ml for i.v. use
DRUG: placebo

Sponsor

Washington University School of Medicine

Collaborators

[object Object]